JCK-AP session 3 (II-JCKAP3)
Pulmonary Circulation

[II-JCKAP3-2] Pharmacological treatment for pediatric patients with congenital heart disease with pulmonary hypertension: Insights from nationwide registry in Japan

^○Taku Ishii¹, Susumu Hosokawa², Naofumi Sumitomo³, Hidekazu Ishida⁴, Shinichi Takatsuki⁵, Keiko Uchida⁶, Hiroyuki Fukushima⁷, Shigetoyo Kogaki⁸, Hiroyuki Yamagishi⁹, Shozaburo Doi¹⁰ (1.Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, 2.Department of Pediatricsese Red Cross Musashino Hospital, Tokyo, 3.Department of Pediatrics, Keio University, Tokyo, 4.Department of Pediatrics, Osaka University, Osaka, 5.Department of Pediatrics, Toho University, Tokyo, 6.Department of Physiology, Tokyo Medical University, Tokyo, 7.Department of Pediatrics, Tokyo Dental Colledge Ichikawa General Hospital, Chiba, 8.Department of Pediatrics, Osaka Medical Center, Osaka, 9.Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, 10.Department of Nursing Discipline, Tokyo Health Care University, Tokyo)

Keywords:

CHD-PAH,pharmacological treatment,efficacy

Password required to view

パスワードは「2024年 ニュースレター No.2(冊子のみ)、会員への配信メール」に記載されています。